Total Funding
54
48
Total FundingGrant raised
Growth Score
-30 pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
234311
A biopharmaceutical company focused on the discovery and development of novel drug therapies for the treatment of sleep apnea.
Arnold S. Lippa: Executive Chairman and Chief Scientific Officer- Timothy Jones: President, Chief Executive Officer & Board Member
About the Company
RespireRx Pharmaceuticals Inc. is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. All of the Company’s current efforts are involved with sleep apnea/hypopnea,
respiratory depression and respiratory distress.
